Clinical Trial Update: Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing therapeutic autologous lymphocytes in combination with cyclophosphamide and aldesleukin for Stage IV melanoma; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Aldesleukin (interleukin-2)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Therapeutic Autologous Lymphocytes

Snippet

Sponsor: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 1 | Status: COMPLETED